Jamie Smith
Media Relations
Email: jamie.smith@molnlycke.com
Phone: +46 723 757507
Gothenburg, Sweden, 4 June 2025.
Mölnlycke is pleased to announce the election of Filippa Stenberg as a deputy board member to its Board of Directors, as of 22 May 2025. Filippa brings over a decade of experience in active ownership with a focus on healthcare investments. She currently serves as a Managing Director of Patricia Industries, part of Investor AB, where she has been instrumental in driving value creation in several globally leading companies.
“We are delighted to welcome Filippa to the Mölnlycke Board,” said Karl-Henrik Sundström, Chairman of the Board. “Her energy, expertise and experience, as well as her strategic vision, will be a tremendous asset to Mölnlycke as we continue to advance our growth journey.”
“I am honoured to join the Mölnlycke Board at such a pivotal time,” added Filippa. “The company has been experiencing strong growth in a healthcare landscape that is continuously evolving. I very much look forward to working with the team to help fulfil the company’s purpose to revolutionise care for people and planet.”
Filippa Stenberg was born in 1985 and is a Swedish citizen. She has been a board member of Swedish Orphan Biovitrum AB since 2021 and recently joined the board of Affibody Medical AB. She has worked as an investment professional at Investor AB since 2012, Chief Strategy Officer at Atlas Antibodies and analyst at Swedbank. She holds an MSc in Business and Economics from the Stockholm School of Economics.
For more information, please contact:
Media Relations
Email: jamie.smith@molnlycke.com
Phone: +46 723 757507
Brunswick, Maine, USA and Gothenburg, Sweden. 23 September 2025. Mölnlycke® Health Care, a global leader in MedTech, headquartered in Gothenburg, Sweden, today celebrates the groundbreaking of a major expansion to its wound care manufacturing capacity in Brunswick, Maine. This milestone marks the beginning of a $135 million investment aimed at significantly increasing Mölnlycke’s manufacturing capacity in the United States.
News to be issued Tuesday 23 September 2025.
Gothenburg, Sweden. 17 September 2025. A new narrative review published in the current issue of Journal of Patient Safety, titled ’Putting Patients at Risk: The Effect of Health Care Provider Burnout on Patient Care in the Operating Room’ reveals alarmingly high levels of burnout among healthcare workers in operating rooms (ORs) and warns of the serious implications for staff well-being, care quality and ultimately patient safety.
Gothenburg, Sweden. 21 August 2025. Mölnlycke®, a world-leading MedTech company, has once again been recognised as a global sustainability leader, earning the prestigious EcoVadis Platinum medal for the second year in a row.
A new peer-reviewed study published in the Journal of Hospital Infection underscores the critical role of double gloving and indicator systems in reducing the risk of undetected glove breaches during surgery.
Gothenburg, Sweden, 26 June 2025. Mölnlycke Health Care, a global leader in MedTech, today announces its largest investment to date: a €115 million expansion of its wound care manufacturing capacity in Brunswick, Maine, USA.
Stockholm/Gothenburg – 24 June, 2025. Mölnlycke Health Care and The Swedish Export Credit Corporation (SEK) have signed a USD 400 million financing agreement to support the healthcare company’s continued global growth and development.
New white paper calls for integration of environmental, human and economic metrics in sustainability assessments of medical technologies.